Last 7 days
0.2%
Last 30 days
-2.1%
Last 90 days
-5.6%
Trailing 12 Months
26.5%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-14 | MIZELL STEVEN | sold | -463,292 | 109 | -4,250 | evp, chief hr officer |
2023-08-03 | Guindo Chirfi | acquired | 3,900,440 | 105 | 36,901 | chief marketing officer |
2023-08-03 | Guindo Chirfi | sold (taxes) | -1,901,440 | 105 | -17,989 | chief marketing officer |
2023-08-03 | MIZELL STEVEN | sold | -474,701 | 105 | -4,500 | evp, chief hr officer |
2023-08-02 | Romanelli Joseph | sold | -6,334 | 107 | -59.00 | president, human health int?l |
2023-08-02 | Romanelli Joseph | sold | -3,221 | 107 | -30.00 | president, human health int?l |
2023-05-04 | LeCointe-Cephas Lisa | sold (taxes) | -32,983 | 118 | -279 | svp chief ethics & com officer |
2023-05-04 | Oosthuizen Johannes Jacobus | sold (taxes) | -52,844 | 118 | -447 | president, u.s. market |
2023-05-04 | Zachary Jennifer | sold | -2,250,830 | 117 | -19,141 | evp, general counsel |
2023-05-04 | Oosthuizen Johannes Jacobus | acquired | 107,226 | 118 | 907 | president, u.s. market |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-19 | BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL | reduced | -17.22 | -536,100 | 4,711,370 | 1.97% |
2023-09-18 | WASHINGTON CAPITAL MANAGEMENT, INC | unchanged | - | 140,022 | 1,795,240 | 1.53% |
2023-09-18 | CAPE ANN SAVINGS BANK | added | 13.19 | 268,635 | 1,448,610 | 0.96% |
2023-09-14 | IMS Capital Management | reduced | -1.45 | 97,589 | 1,514,500 | 0.84% |
2023-09-13 | CGC Financial Services, LLC | new | - | 173,132 | 173,132 | 0.11% |
2023-09-12 | Prosperity Wealth Management, Inc. | new | - | 211,048 | 211,048 | 0.14% |
2023-09-12 | Prosperity Financial Group, Inc. | added | 2.91 | 40,392 | 388,287 | 0.34% |
2023-09-12 | Farther Finance Advisors, LLC | added | 10.48 | 101,691 | 614,461 | 0.13% |
2023-09-12 | DCM Advisors, LLC | reduced | -15.68 | -88,626 | 948,889 | 0.41% |
2023-09-11 | BLUEFIN CAPITAL MANAGEMENT, LLC | new | - | 426,943 | 426,943 | 0.08% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 8.96% | 227,205,978 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 8.5% | 215,011,385 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 8.36% | 211,202,531 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 7.8% | 198,224,264 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.24% | 208,410,644 | SC 13G/A | |
Feb 05, 2021 | blackrock inc. | 7.8% | 196,213,804 | SC 13G/A | |
Feb 12, 2020 | vanguard group inc | 8.26% | 210,542,333 | SC 13G/A | |
Feb 05, 2020 | blackrock inc. | 7.5% | 190,783,225 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Aug 15, 2023 | 4 | Insider Trading | |
Aug 14, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 07, 2023 | 10-Q | Quarterly Report | |
Aug 04, 2023 | 4 | Insider Trading | |
Aug 04, 2023 | 4 | Insider Trading | |
Aug 03, 2023 | 4 | Insider Trading | |
Aug 03, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 01, 2023 | 8-K | Current Report | |
Jul 05, 2023 | 4 | Insider Trading | |
Jul 05, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
LLY | 512.5B | 29.5B | 3.56% | 89.32% | 78.88 | 17.36 | 1.53% | 14.16% |
JNJ | 423.3B | 97.8B | -2.65% | 0.10% | 32.43 | 4.33 | 2.29% | -28.92% |
MRK | 272.8B | 58.3B | -2.13% | 26.48% | 17.88 | 4.63 | 2.00% | -81.24% |
PFE | 189.8B | 77.9B | -9.16% | -24.26% | 8.84 | 2.44 | -23.04% | -26.74% |
BMY | 150.1B | 45.2B | -5.06% | -15.06% | 23.72 | 3.25 | -4.15% | 20.34% |
MID-CAP | ||||||||
RETA | 6.5B | - | 1.75% | 544.26% | -74.04 | 4.1K | -86.94% | 71.24% |
PRGO | 4.5B | 4.6B | -11.49% | -16.32% | -66.69 | 0.98 | 6.60% | 42.04% |
SMALL-CAP | ||||||||
TLRY | 1.9B | 627.1M | -7.75% | -1.79% | -1.34 | 3.1 | -0.20% | -204.67% |
SUPN | 1.5B | 634.0M | -11.88% | -19.94% | 34.62 | 2.37 | 0.62% | -24.59% |
INVA | 832.3M | 244.3M | -4.13% | 4.68% | 4.22 | 3.41 | -39.50% | -4.99% |
CRON | 830.8M | 109.5M | 21.79% | -27.57% | -5.79 | 7.59 | -2.66% | -32.13% |
CGC | 480.0M | 453.3M | 110.37% | -71.69% | -0.39 | 1.06 | -16.04% | 55.90% |
ACRS | 479.1M | 31.2M | -7.77% | -52.62% | -4.55 | 15.37 | 407.54% | -26.47% |
OCUL | 269.4M | 54.6M | -13.04% | -44.44% | -2.97 | 4.93 | 9.39% | -179.16% |
ENDP | - | 2.2B | - | - | - | - | -22.39% | 63.59% |
12.2%
11.9%
12.7%
12.4%
16.5%
0%
0%
Y-axis is the maximum loss one would have experienced if Merck was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 0.8% | 58,311 | 57,869 | 59,283 | 58,974 | 57,169 | 53,978 | 48,704 | 46,131 | 43,906 | 41,857 | 41,518 | 36,488 | 37,956 | 40,363 | 39,121 | 45,971 | 44,368 | 43,073 | 42,294 | 41,729 | 41,260 |
S&GA Expenses | 1.9% | 10,388 | 10,198 | 10,042 | 10,185 | 10,001 | 9,770 | 9,634 | 9,423 | 9,147 | 8,951 | 8,955 | 8,429 | 8,958 | 9,585 | 9,455 | 10,369 | 10,223 | 10,019 | 10,102 | 10,101 | 10,117 |
R&D Expenses | 69.0% | 25,771 | 15,248 | 13,548 | 12,841 | 10,887 | 12,410 | 12,245 | 14,966 | 15,870 | 13,634 | 13,397 | 10,043 | 9,898 | 10,002 | 9,724 | 9,538 | 8,402 | 8,487 | 9,752 | 9,853 | 12,198 |
EBITDA | -100.0% | - | 17,060 | 18,244 | 18,664 | 21,157 | 18,246 | 16,285 | 11,760 | 9,660 | 14,490 | 13,279 | 13,005 | 11,945 | 12,412 | 11,716 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.29* | 0.31* | 0.32* | 0.37* | 0.34* | 0.33* | 0.28* | 0.23* | 0.28* | 0.28* | 0.34* | 0.31* | 0.31* | 0.30* | - | - | - | - | - | - |
Earnings Before Taxes | -64.5% | 5,411 | 15,233 | 16,444 | 16,840 | 18,523 | 15,753 | 13,879 | 7,425 | 4,865 | 5,889 | 5,863 | 7,783 | 7,424 | 7,942 | 7,171 | 11,277 | 11,595 | 10,422 | 8,701 | 7,975 | 5,510 |
EBT Margin | -100.0% | - | 0.26* | 0.28* | 0.29* | 0.32* | 0.29* | 0.28* | 0.25* | 0.20* | 0.19* | 0.18* | 0.22* | 0.20* | 0.20* | 0.18* | - | - | - | - | - | - |
Net Income | -76.1% | 3,111 | 13,030 | 14,519 | 15,260 | 16,579 | 14,180 | 13,049 | 7,197 | 5,571 | 7,028 | 7,067 | 11,518 | 10,478 | 10,146 | 9,843 | 9,313 | 9,362 | 8,399 | 6,220 | 3,347 | 1,341 |
Net Income Margin | -100.0% | - | 0.23* | 0.24* | 0.26* | 0.29* | 0.26* | 0.27* | 0.17* | 0.13* | 0.14* | 0.15* | 0.30* | 0.28* | 0.25* | 0.25* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 15,673 | 19,095 | 19,760 | 18,955 | 16,092 | 13,122 | 12,033 | 9,409 | 11,337 | 10,253 | 11,041 | 13,094 | 12,811 | 13,440 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -3.1% | 104,469 | 107,796 | 109,160 | 107,081 | 107,095 | 106,668 | 105,694 | 93,494 | 90,688 | 90,847 | 91,588 | 89,800 | 90,615 | 84,913 | 84,397 | 83,331 | 83,965 | 82,354 | 82,637 | 85,130 | 85,040 |
Current Assets | -10.3% | 29,977 | 33,402 | 35,722 | 33,561 | 32,116 | 31,184 | 30,266 | 31,058 | 28,665 | 26,909 | 27,764 | 26,577 | 29,343 | 26,174 | 27,483 | 26,142 | 24,298 | 25,351 | 25,875 | 26,836 | 24,064 |
Cash Equivalents | -41.7% | 5,660 | 9,707 | 12,694 | 11,145 | 9,753 | 8,614 | 8,167 | 10,046 | 8,630 | 6,882 | 8,153 | 7,401 | 11,147 | 7,460 | 9,934 | 7,871 | 6,660 | 8,077 | 7,967 | 7,828 | 5,312 |
Inventory | 1.1% | 5,930 | 5,863 | 5,911 | 5,614 | 5,535 | 5,774 | 5,953 | 5,603 | 5,499 | 6,402 | 5,554 | 6,128 | 6,056 | 5,846 | 5,978 | 5,855 | 5,847 | 5,712 | 5,440 | 5,416 | 5,178 |
Net PPE | 2.2% | 22,231 | 21,758 | 21,422 | 20,424 | 20,059 | 19,747 | 19,279 | 18,565 | 18,064 | 18,295 | 17,000 | 16,919 | 15,789 | 15,269 | 14,297 | 14,287 | 13,862 | 13,506 | 13,291 | 12,755 | 12,626 |
Goodwill | -0.1% | 21,195 | 21,209 | 21,204 | 21,160 | 21,213 | 21,258 | 21,264 | 18,862 | 18,873 | 20,212 | 18,882 | 20,248 | 239 | 19,767 | 18,069 | 19,480 | 19,490 | 1,376 | 18,253 | 18,258 | 18,274 |
Current Liabilities | 1.1% | 23,394 | 23,131 | 24,239 | 22,998 | 23,168 | 22,316 | 23,872 | 23,728 | 21,906 | 26,361 | 27,327 | 20,405 | 22,178 | 23,483 | 22,220 | 20,684 | 20,085 | 18,543 | 22,206 | 18,586 | 18,128 |
LT Debt, Non Current | 21.4% | 34,072 | 28,074 | 28,745 | 28,482 | 28,684 | 30,586 | 30,690 | 22,907 | 24,033 | 24,002 | 25,360 | 26,321 | 26,156 | 21,637 | 22,736 | 22,677 | 22,771 | 22,721 | 19,806 | 19,936 | 19,959 |
Shareholder's Equity | -17.5% | 38,693 | 46,905 | 45,991 | 44,458 | 43,318 | 40,953 | 38,257 | 35,863 | 33,388 | 27,039 | 25,404 | 29,270 | 27,744 | 26,300 | 26,001 | 26,925 | 27,737 | 27,670 | 26,882 | 32,656 | 32,766 |
Retained Earnings | -12.6% | 54,198 | 62,039 | 61,081 | 59,928 | 58,437 | 56,252 | 53,696 | 51,691 | 48,777 | 48,888 | 47,362 | 51,107 | 49,724 | 48,272 | 46,602 | 45,804 | 45,295 | 44,065 | 42,579 | 42,189 | 41,523 |
Additional Paid-In Capital | -0.6% | 44,219 | 44,467 | 44,379 | 44,243 | 44,115 | 44,275 | 44,238 | 44,149 | 44,039 | 39,613 | 39,588 | 39,489 | 39,373 | 39,697 | 39,660 | 39,561 | 39,484 | 38,768 | 38,808 | 39,762 | 39,741 |
Accumulated Depreciation | 1.0% | 18,432 | 18,256 | 17,985 | 17,921 | 17,798 | 18,498 | 18,192 | 18,155 | 18,236 | 18,732 | 18,162 | 18,572 | 18,182 | 17,706 | 17,686 | 17,281 | 17,049 | 16,623 | 16,324 | 16,568 | 16,567 |
Minority Interest | -31.0% | 49.00 | 71.00 | 67.00 | 66.00 | 75.00 | 70.00 | 73.00 | 69.00 | 94.00 | 94.00 | 87.00 | 84.00 | 102 | 95.00 | 94.00 | 87.00 | 102 | 131 | 181 | 234 | 237 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -3.8% | 15,075 | 15,673 | 19,095 | 19,760 | 18,955 | 16,643 | 13,122 | 11,437 | 8,222 | 8,150 | 7,617 | 4,445 | 7,089 | 8,255 | 8,884 | 12,238 | 10,805 | 11,103 | 10,922 | 11,349 | 7,385 |
Share Based Compensation | 5.7% | 598 | 566 | 541 | 515 | 493 | 488 | 479 | 472 | 481 | 470 | 441 | 437 | 412 | 402 | 388 | 392 | 382 | 361 | 348 | 341 | 326 |
Cashflow From Investing | -168.7% | -16,512 | -6,146 | -4,960 | -15,261 | -15,360 | -16,908 | -16,421 | -9,069 | -10,094 | -8,251 | -9,193 | -5,159 | -2,882 | -4,525 | -2,529 | 312 | 1,781 | 4,879 | 4,314 | 2,078 | 1,089 |
Cashflow From Financing | 68.4% | -2,552 | -8,087 | -9,119 | -2,358 | -1,930 | 2,109 | 3,097 | -738 | -2,315 | -3,440 | -2,832 | -6,215 | -5,516 | -8,737 | -8,861 | -12,416 | -11,169 | -12,052 | -13,160 | -13,379 | -10,938 |
Dividend Payments | 1.6% | 7,235 | 7,120 | 7,012 | 6,905 | 6,807 | 6,710 | 6,610 | 6,509 | 6,405 | 6,309 | 6,215 | 6,078 | 5,927 | 5,818 | 5,695 | 5,567 | 5,458 | 5,301 | 5,172 | 5,178 | 5,176 |
Buy Backs | 226.8% | 487 | 149 | - | 18.00 | 601 | 840 | 840 | 822 | 239 | - | 1,281 | 2,331 | 3,736 | 4,971 | 4,780 | 9,663 | 9,254 | 9,615 | 9,091 | 4,860 | 4,023 |
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Statement [Abstract] | ||||
Sales | $ 15,035 | $ 14,593 | $ 29,522 | $ 30,494 |
Costs, Expenses and Other | ||||
Cost of sales | 4,024 | 4,216 | 7,951 | 9,596 |
Selling, general and administrative | 2,702 | 2,512 | 5,182 | 4,834 |
Research and development | 13,321 | 2,798 | 17,597 | 5,374 |
Restructuring costs | 151 | 142 | 218 | 194 |
Other (income) expense, net | 172 | 438 | 259 | 1,148 |
Total Costs, Expenses and Other | 20,370 | 10,106 | 31,207 | 21,146 |
(Loss) Income Before Taxes | (5,335) | 4,487 | (1,685) | 9,348 |
Income Tax Provision | 637 | 538 | 1,462 | 1,092 |
Net (Loss) Income | (5,972) | 3,949 | (3,147) | 8,256 |
Less: Net Income Attributable to Noncontrolling Interests | 3 | 5 | 7 | 2 |
Net (Loss) Income Attributable to Merck & Co., Inc. | $ (5,975) | $ 3,944 | $ (3,154) | $ 8,254 |
Basic (Loss) Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | $ (2.35) | $ 1.56 | $ (1.24) | $ 3.26 |
(Loss) Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | $ (2.35) | $ 1.55 | $ (1.24) | $ 3.25 |
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current Assets | ||
Cash and cash equivalents | $ 5,660 | $ 12,694 |
Short-term investments | 718 | 498 |
Accounts receivable (net of allowance for doubtful accounts of $86 in 2023 and $72 in 2022) | 11,030 | 9,450 |
Inventories (excludes inventories of $3,220 in 2023 and $2,938 in 2022 classified in Other assets - see Note 7) | 5,930 | 5,911 |
Other current assets | 6,639 | 7,169 |
Total current assets | 29,977 | 35,722 |
Investments | 1,214 | 1,015 |
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,432 in 2023 and $17,985 in 2022 | 22,231 | 21,422 |
Goodwill | 21,195 | 21,204 |
Other Intangibles, Net | 19,665 | 20,269 |
Other Assets | 10,187 | 9,528 |
Total Assets | 104,469 | 109,160 |
Current Liabilities | ||
Loans payable and current portion of long-term debt | 2,839 | 1,946 |
Trade accounts payable | 3,442 | 4,264 |
Accrued and other current liabilities | 13,747 | 14,159 |
Income taxes payable | 1,489 | 1,986 |
Dividends payable | 1,877 | 1,884 |
Total current liabilities | 23,394 | 24,239 |
Long-Term Debt | 34,072 | 28,745 |
Deferred Income Taxes | 996 | 1,795 |
Other Noncurrent Liabilities | 7,265 | 8,323 |
Merck & Co., Inc. Stockholders’ Equity | ||
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2023 and 2022 | 1,788 | 1,788 |
Other paid-in capital | 44,219 | 44,379 |
Retained earnings | 54,198 | 61,081 |
Accumulated other comprehensive loss | (4,900) | (4,768) |
Stockholders' equity before deduction for treasury stock | 95,305 | 102,480 |
Less treasury stock, at cost: 1,037,678,033 shares in 2023 and 1,039,269,638 shares in 2022 | 56,612 | 56,489 |
Total Merck & Co., Inc. stockholders’ equity | 38,693 | 45,991 |
Noncontrolling Interests | 49 | 67 |
Total equity | 38,742 | 46,058 |
Liabilities and Equity | $ 104,469 | $ 109,160 |